Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
10.97B
Market cap10.97B
Price-Earnings ratio
36.65
Price-Earnings ratio36.65
Dividend yield
Dividend yield
Average volume
1.48M
Average volume1.48M
High today
$159.55
High today$159.55
Low today
$159.36
Low today$159.36
Open price
$156.41
Open price$156.41
Volume
917.00
Volume917.00
52 Week high
$354.88
52 Week high$354.88
52 Week low
$138.79
52 Week low$138.79

Stock Snapshot

With a market cap of 10.97B, Insulet(PODD) trades at $159.55. The stock has a price-to-earnings ratio of 36.65.

On 2026-07-10, Insulet(PODD) stock moved within a range of $159.36 to $159.55. With shares now at $159.55, the stock is trading +0.1% above its intraday low and 0.0% below the session's peak.

Trading volume for Insulet(PODD) stock has reached 917, versus its average volume of 1.48M.

The stock's 52-week range extends from a low of $138.79 to a high of $354.88.

The stock's 52-week range extends from a low of $138.79 to a high of $354.88.

PODD News

MarketWatch 2d
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch

...

Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Nasdaq 4d
Insulet Now #472 Largest Company, Surpassing Fox

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Insulet Corp (Symbol: PODD) has taken over the #472 spo...

Insulet Now #472 Largest Company, Surpassing Fox
Benzinga 4d
FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports

The recall follows concerns that some pods may fail to deliver the intended amount of insulin, increasing the risk of dangerously high blood sugar levels and di...

FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports

Analyst ratings

86%

of 28 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More PODD News

Nasdaq 4d
Insulet Launches Omnipod 5 Automated Insulin Delivery System In Spain

(RTTNews) - Insulet Corporation (PODD) on Monday said it has launched its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data management platf...

Insulet Launches Omnipod 5 Automated Insulin Delivery System In Spain
TipRanks 4d
Insulet announces launch of Omipod 5, Omnipod Discover in Spain

Insulet (PODD) Corporation announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System and its proprietary data management system Omnipod...

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.